Who are the key players in North America RNA Analysis Market industry?

The top 5 players in the North America RNA Analysis Market are Thermo Fisher Scientific, Illumina Inc., Agilent Technologies, Bio-Rad Laboratories, and Qiagen. These companies dominate the market with advanced RNA sequencing platforms, innovative kits, and strong distribution networks, continuously investing in R&D for next-generation RNA analysis solutions.

What is the North America RNA Analysis Market growth?

The North America RNA Analysis Market is witnessing robust growth, driven by rising demand for precision medicine and genomics. In 2023, Thermo Fisher Scientific reported increased adoption of its RNA sequencing solutions, contributing to market expansion, especially across clinical research and pharmaceutical development sectors.

Which segment accounted for the largest North America RNA Analysis Market share?

The largest market share in North America RNA Analysis is held by the Clinical Diagnostics application segment. This dominance is fueled by increasing adoption of RNA-based tests for disease detection, personalized medicine, and cancer research, with hospitals and diagnostics labs utilizing advanced platforms from Illumina and Agilent.

What are the factors driving the North America RNA Analysis Market?

Key factors propelling market growth include rising prevalence of genetic disorders and cancer, growing investment in genomics research, and advances in RNA sequencing technologies. For example, Illumina’s development of high-throughput NGS platforms has expanded research capabilities, accelerating adoption within biopharmaceutical and academic sectors.

Which type accounted for the largest North America RNA Analysis Market share?

Sequencing-based RNA analysis dominates the North America RNA Analysis Market by type, driven by its comprehensive data output and ability to uncover novel transcripts. Companies like Illumina and Thermo Fisher Scientific lead this segment with their high-throughput RNA-seq platforms widely used in both research and clinical settings.

Home Healthcare

North America RNA Analysis Market Size & Share Analysis - Growth Trends and Forecast (2026 - 2035)

Name: North America RNA Analysis Market
Brand: Bussiness Insights

North America RNA Analysis Market: by Type (Reagents/Consumables, Instruments, Services), Application (Drug Discovery, Clinical Diagnostics, Toxicogenomics, Comparative Transcriptomics, Others), Distribution Channels (Direct Tender, Retail Sales, Online Sales, Distributors/Wholesalers, Others), Technology (PCR, Sequencing, Microarray, RNA Interference, Others), Organization Size (Small, Medium, Large) and By North America Historical & Forecast Period (2020-2035) Comprehensive Study 2025

Last Updated: 31-07-2025 | Format: PDF | Report ID:20289 | Author: Lily

RD TOC Segmentation Research Methodology Request For Free Sample

North America RNA Analysis Market (2025-2035) - Comprehensive Analysis and Forecast

The North America RNA Analysis Market is seeing robust growth owing to technological innovations, expanding applications in clinical diagnostics and drug discovery, and substantial investments by key industry players. This market is segmented by type, application, technology, distribution channels, and organization size, with a strong presence by established companies. The increasing focus on personalized medicine and genomics research is expected to further drive market expansion through 2035.

Latest Market Dynamics

Key Drivers

Rising adoption of RNA sequencing in clinical diagnostics, propelled by advanced platforms from Illumina and Thermo Fisher Scientific that enable more precise disease profiling as of 2025.

Integration of artificial intelligence and machine learning in RNA data analysis platforms is increasing, as seen in 2025 collaborations between Bio-Rad Laboratories and cloud analytics companies to streamline big data processing.
Growing demand for non-invasive liquid biopsy technologies utilizing RNA biomarkers, led by Roche and PerkinElmer’s latest assay solutions designed for oncology applications.

Expansion into personalized medicine, with Pacific Biosciences and Oxford Nanopore Technologies developing novel long-read sequencing solutions tailored for rare disease profiling.
Surge in demand for cloud-based bioinformatics services, driven by New England Biolabs and Lexogen partnering with SaaS providers to offer scalable data analysis for academic and clinical researchers.

Data privacy and regulatory complexities, as highlighted by recent FDA guidelines affecting access and sharing of RNA datasets among top vendors like Thermo Fisher and Bio-Rad.
Technical challenges in standardizing workflow protocols across diverse platforms, with Agilent Technologies and Illumina addressing reproducibility in multi-center trials.

High capital investment requirements for next-generation sequencing platforms, limiting smaller labs’ market entry, as seen with recent pricing strategies of Oxford Nanopore and Pacific Biosciences.
Limited skilled workforce for advanced RNA bioinformatics, causing workflow bottlenecks for expanding clinical laboratories, noted in QIAGEN and Promega’s 2025 training program launches across North America.

In 2025, reagents and consumables command the largest market share among RNA analysis types, reflecting their critical role in both research and clinical workflows. Instruments and services are also key contributors, driven by ongoing laboratory automation and increasing demand for outsourcing analytical expertise. Software and kits round out the segment, benefitting from packaged solutions and integrated workflows. This division highlights the essential nature of consumables in recurring market revenue and the growing reliance on advanced analytical and informatics services.

Drug discovery maintains a leading share in the North America RNA Analysis Market by application in 2025, fueled by biopharmaceutical industry growth and rising investments in transcriptomics for target identification. Clinical diagnostics is also significant, propelled by advances in personalized medicine and non-invasive diagnostics. Toxicogenomics and comparative transcriptomics represent emerging but rapidly growing segments, as research institutions and healthcare providers increase their adoption of RNA-based methods for disease mechanism elucidation and biomarker development.

The North America RNA Analysis Market is projected to grow from 2,100 Million USD in 2020 to approximately 7,850 Million USD by 2035, reflecting a strong CAGR. Growth is driven by expanded applications in both clinical diagnostics and drug discovery, coupled with increased adoption of advanced sequencing platforms and data analytics. The market shows accelerating gains post-2025 as large-scale genomics initiatives and healthcare digitization further fuel demand.

The market’s year-on-year growth rates accelerate post-2025, peaking around 9% CAGR by 2030. The increase is attributed to technological breakthroughs in sequencing and the scaling-up of biopharmaceutical and clinical genomics applications. Growth stabilizes by 2035 as the market matures, with ongoing innovation and increasing accessibility sustaining above-average expansion over the period.

The United States holds a dominant share of the North America RNA Analysis Market in 2025, reflecting its strong biotechnological infrastructure and major industry players' presence. Canada represents the second-largest segment, supported by expanding research spending and government funding. Mexico’s share, while smaller, is growing due to investments in healthcare infrastructure and scientific research capabilities. This regional distribution highlights the significant market leadership of the US in North American RNA analysis.

Thermo Fisher Scientific, Illumina, and Agilent Technologies collectively account for the largest market shares in 2025. Their strong portfolios in platforms, reagents, and services, combined with active innovation pipelines and strategic partnerships, have enabled these companies to capture substantial portions of the North America RNA Analysis Market. QIAGEN and Bio-Rad Laboratories also maintain significant presence, driving competition and fostering technology advancements.

Academic and research institutes remain the largest buyers in the North America RNA Analysis Market for 2025, driven by ongoing genomics research and collaborative projects. Pharmaceutical and biotechnology companies are significant purchasers, leveraging RNA analysis in drug discovery and pipeline development. Clinical laboratories make up a growing proportion, reflecting the market’s transition towards routine clinical diagnostics and precision medicine deployment.

Metrics	Details
Years	2020-2035
Base Year	2025
Market Size	3800
Regions	United States, Canada, Mexico
Segments	Reagents/Consumables, Instruments, Services, Software, Kits, Accessories; Drug Discovery, Clinical Diagnostics, Toxicogenomics, Comparative Transcriptomics, Disease Research, Others
Players	Thermo Fisher Scientific, Illumina, Agilent Technologies, QIAGEN, Bio-Rad Laboratories, Merck KGaA, F. Hoffmann-La Roche AG, New England Biolabs, Takara Bio, Promega Corporation, PerkinElmer, Fluidigm Corporation, Pacific Biosciences, Oxford Nanopore Technologies, Lexogen GmbH

June 2024: Illumina introduced a new high-throughput sequencing system designed to enhance RNA analysis workflows in clinical research and precision medicine.
July 2024: Thermo Fisher Scientific expanded its RNA analysis reagents portfolio with the launch of next-generation library prep kits tailored for single-cell applications.
August 2024: Agilent Technologies formed a collaboration with major pharmaceutical companies to co-develop standardized RNA analysis platforms and data reporting protocols.
September 2024: Bio-Rad Laboratories announced the release of an updated digital droplet PCR solution for ultra-sensitive RNA quantification in oncology diagnostics.
October 2024: QIAGEN launched upgraded cloud-based bioinformatics software enabling streamlined analysis and data visualization for advanced RNA sequencing projects.

About the Author

Lily

Senior Market Research Analyst

Lily is a Senior Market Research Analyst specializing in market research, industry analysis, and business consulting across Healthcare. Lily brings a commercially grounded perspective to sectors shaped by changing demand, innovation, and competitive dynamics, helping turn complex market trends into clear strategic insights for business decision-makers. With 10+ years of experience across research, analytics, and strategic advisory roles, Lily has helped organizations translate data into actionable growth strategies.

HealthcareMarket ResearchIndustry AnalysisStrategic Consulting

Key Questions Answered

»What is the market size and growth rate of the global and regional market by various segments?
»What is the market size and growth rate of the market for selective countries?
»Which region or sub-segment is expected to drive the market in the forecast period?
»What factors are estimated to drive and restrain the market growth?
»What are the key technological and market trends shaping the market?
»What are the key opportunities in the market?
»What are the key companies operating in the market?
»Which company accounted for the highest market share?

Download Sample

Why Choose Bussiness Insights?

»Strong Industry Focus
»Extensive Product Offerings
»Customer Research Services
»Robust Research Methodology
»Comprehensive Reports
»Latest Technological Developments
»Value Chain Analysis
»Potential Market Opportunities
»Growth Dynamics
»Quality Assurance
»Post-sales Support
»Regular Report Updates

Speak to Analyst

North America RNA Analysis Market Size & Share Analysis - Growth Trends and Forecast (2026 - 2035)

North America RNA Analysis Market (2025-2035) - Comprehensive Analysis and Forecast

Latest Market Dynamics

Key Drivers

Key Trends

Key Opportunities

Key Challenges

Key Restraints

RNA Analysis Market Share by Type (2025)

RNA Analysis Market Share by Application (2025)

RNA Analysis Market Revenue (USD Million): 2020-2035

Year-on-Year Growth Rate (%) of North America RNA Analysis Market: 2020-2035

RNA Analysis Market Share by Region (2025)

RNA Analysis Market Share by Major Players (2025)

RNA Analysis Market Share by Buyer Type (2025)

Study Coverage

Key Recent Developments

Frequently Asked Questions

About the Author

Related Reports